Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Veronika C. Stark"'
Autor:
Veronika C. Stark, Jakob Olfe, Daniel Diaz-Gil, Yskert von Kodolitsch, Rainer Kozlik-Feldmann, Johannes Reincke, Maria Stark, Peter Wiegand, Tanja Zeller, Thomas S. Mir
Publikováno v:
Frontiers in Pediatrics, Vol 12 (2024)
IntroductionTransforming growth factor β (TGFβ) metabolism plays an important role in the pathogenesis of Marfan syndrome (MFS). Accordingly, drug therapy uses TGFβ receptor blockade to slow down the cardiovascular manifestations, above all aortic
Externí odkaz:
https://doaj.org/article/dcd0c6f19cb2415fbf4f173e5b957b85
Autor:
Veronika C. Stark, Florian Arndt, Gesa Harring, Yskert von Kodolitsch, Rainer Kozlik-Feldmann, Goetz C. Mueller, Kristoffer J. Steiner, Thomas S. Mir
Publikováno v:
Diseases, Vol 3, Iss 1, Pp 24-33 (2015)
Due to age dependent organ manifestation, diagnosis of Marfan syndrome (MFS) is a challenge, especially in childhood. It is important to identify children at risk of MFS as soon as possible to direct those to appropriate treatment but also to avoid s
Externí odkaz:
https://doaj.org/article/bc1aa5f856474d709ce5ef03e6a894d1
Tricuspid valve prolapse as an early predictor for severe phenotype in children with Marfan syndrome
Autor:
Veronika C. Stark, Jakob Olfe, Jannis Pesch, Enver Tahir, Julius M. Weinrich, Peter Wiegand, Rainer Kozlik‐Feldmann, Yskert Kodolitsch, Thomas S. Mir
Publikováno v:
Acta Paediatrica. 111:1261-1266
In Marfan syndrome, various cardiovascular pathologies, such as aortic dilatation and mitral valve pathologies, already occur in childhood and determine course of the disease. This study aimed to establish additional cardiovascular risk markers for s
Autor:
Veronika C, Stark, Flemming, Hensen, Kerstin, Kutsche, Fanny, Kortüm, Jakob, Olfe, Peter, Wiegand, Yskert, von Kodolitsch, Rainer, Kozlik-Feldmann, Götz C, Müller, Thomas S, Mir
Publikováno v:
Genes
Currently, no reliable genotype–phenotype correlation is available for pediatric Marfan patients in everyday clinical practice. We investigated correlations of FBN1 variants with the prevalence and age of onset of Marfan manifestations in childhood